You are here

Home » Content

Böbrek Naklinin Global Rolü

The Global Role of Kidney Transplantation

Journal Name:

  • Türk Nefroloji, Diyaliz ve Transplantasyon Dergisi

Publication Year:

  • 2012
DOI: 
DOI 10.5262/tndt.2012.1001.01
Author NameUniversity of Author
Abstract (2. Language): 
World Kidney Day on March 8th 2012 provides a chance to reflect on the success of kidney transplantation as a therapy for end stage kidney disease that surpasses dialysis treatments both for the quality and quantity of life that it provides and for its cost effectiveness. Anything that is both cheaper and better, but is not actually the dominant therapy, must have other drawbacks that prevent replacement of all dialysis treatment by transplantation. The barriers to universal transplantation as the therapy for end stage kidney disease include the economic limitations which, in some countries place transplantation, appropriately, at a lower priority than public health fundamentals such as clean water, sanitation and vaccination. Even in high income countries the technical challenges of surgery and the consequences of immunosuppression restrict the number of suitable recipients, but the major finite restrictions on kidney transplantation rates are the shortage of donated organs and the limited medical, surgical and nursing workforces with the required expertise. These problems have solutions which involve the full range of societal, professional, governmental and political environments. World Kidney Day is a call to deliver transplantation therapy to the one million people a year who have a right to benefit.
Bookmark/Search this post with
Abstract (Original Language): 
8 Mart 2012 tarihindeki Dünya Böbrek Günü böbrek naklinin son dönem böbrek hastalığında hem sağladığı yaşam kalitesi, hem miktarı, hem de maliyet etkinliği açısından diyaliz tedavilerinden daha iyi olan bir tedavi olarak başarısını düşünme fırsatı yaratmaktadır. Daha ucuz ve daha iyi olan ama aslında dominant tedavi olmayan her tedavide olduğu gibi diyaliz tedavisinin yerini naklin almasını önleyen başka sakıncaları olmalıdır. Son dönem böbrek hastalığı için tedavi olarak evrensel nakle engeller arasında bazı ülkelerde uygun olarak naklin temiz su, temizlik ve aşılama gibi kamu sağlığı temellerinden daha düşük öncelik almasına neden olan mali sınırlamalar vardır. Yüksek gelire sahip ülkelerde bile cerrahinin teknik zorlukları ve immünsüpresyonun sonuçları uygun alıcı sayısını sınırlar ama böbrek nakli oranlarındaki esas sınırlamalar bağışlanan organların kısıtlı sayısı ve gerekli uzmanlığa sahip sınırlı tıbbi, cerrahi ve hemşirelik işgücüdür. Bu problemlerin sosyal, mesleki, idari ve politik ortamların tümünü ilgilendiren çözümleri vardır. Dünya Böbrek Günü, faydalanma hakkı olan yılda bir milyon kişiye nakil tedavisi sağlamak için bir çağrıdır.
FULL TEXT (PDF): 
PDF icon arastrmx_172977_21_pp_1-6.pdf
  • 1
1-6
  • Turkish

REFERENCES

References: 

1. Murray JE: Ronald Lee Herrick Memorial: June 15, 1931-December
27, 2010. Am J Transplant 2011; 11 (3): 419
2. http://www.anzdata.org.au/anzdata/AnzdataReport/33rdReport/
Ch08.pdf. Accessed 29/11/2011
3. Shimmura H, Tanabe K, Ishida H, Tokumoto T, Ishikawa N,
Miyamoto N, Shirakawa H, Setoguchi K, Nakajima I, Fuchinoue
S, Teraoka S, Toma H: Lack of correlation between results of
ABO-incompatible living kidney transplantation and anti-ABO
blood type antibody titers under our current immunosuppression.
Transplantation 2005; 80 (7): 985-988
4. Peng A, Vo A, Jordan SC: Transplantation of the highly human
leukocyte antigen–sensitized patient: Long-term outcomes and
future directions. Transplantation Reviews 2006; 20: 46-156
5. Warren DS, Montgomery RA: Incompatible kidney transplantation:
Lessons from a decade of desensitization and paired kidney
exchange. Immunol Res 2010; 47 (1-3): 257-264
6. Weber CL, Rush DN, Jeffery JR, Cheang M, Karpinski ME: Kidney
transplantation outcomes in Canadian aboriginals. Am J Transplant
2006; 6 (8): 1875-1881
7. Gordon EJ, Ladner DP, Caicedo JC, Franklin J: Disparities in kidney
transplant outcomes: A review. Semin Nephrol 2010; 30: 81-89
8. Collins JF: Kidney disease in Maori and Pacific people in New
Zealand. Clin Nephrol 2010; 74 (1): 61-65
9. Rizvi SA, Naqvi SA, Zafar MN, Hussain Z, Hashmi A, Hussain M,
Akhtar F, Ahmed E: Living related renal transplants with lifelong
follow-up. A model for the developing world. Clin Nephrol 2010;
74 (1): 142-149
10. Monteon FJ, Gomez B, Valdespino C, Chavez S, Sandoval M, Flores
A, Herrera R, Ramos F, Hernandez A, Camarena JL, Páez H, Ramírez
J, Nieves JJ, Bassols A, Rosales G, Romero O, Paredes G, Andrade
J, Ruelas S, Contreras AM: The kidney transplant experience at
Hospital de Especialidades, Centro Médico Nacional de Occidente,
IMSS, Guadalajara México. Clin Transpl 2003; 165-174
11. Jha V: Current status of end-stage renal disease care in South Asia.
Ethn Dis 2009; 19 (1): 27-32
12. Wolfe RA, Ashby VB, Milford EL, Ojo AO, Ettenger RE, Agodoa
LY, Held PJ, Port FK: Comparison of mortality in all patients on
dialysis, patients on dialysis awaiting transplantation and recipients
of a first cadaveric transplant. New Eng J Med 1999; 341 (23):
1725-1730
13. Sakhuja V, Sud K: End-stage renal disease in India and Pakistan:
Burden of disease and management issues. Kidney Int Suppl 2003;
83: 115-118
14. Rizvi SA, Naqvi SA, Zafar MN, Hussain Z, Hashmi A, Hussain M,
Akhtar SF, Ahmed E, Aziz T, Sultan G, Sultan S, Mehdi SH, Lal M,
Ali B, Mubarak M, Faiq SM: A Renal Transplantation Model for
developing countries. Am J Transplant 2011: 11 (11): 2302-2307
15. Sud K, et al: Indian J of Nephrology 1999; 9: 83-91
16. Meier-Kriesche HU, Kaplan B: Waiting time on dialysis as the
strongest modifiable risk factor for renal transplant outcomes.
Transplantation 2002; 74 (10): 1377-1381
17. Kasiske BL, Snyder JJ, Matas AJ, Ellison MD, Gill JS, Kausz
AT: Pre-emptive kidney transplantation: The advantage and the
advantaged. J Am Soc Nephrol 2002; 13 (5): 1358-1364
18. http://www.who.int/transplantation/knowledgebase/en/Accessed
29/11/2011
19. Yeates K: Health Disparities in renal disease in Canada. Semin
Nephrol 2010; 30: 12-18
20. Alexander GC, Sehgal AR: Barriers to cadaveric renal transplantation
among blacks, women and the poor. JAMA 1998; 280 (13): 1148-
1152
21. McDonald S: Incidence and treatment of ESRD among indigenous
peoples of Australasia. Clin Nephrol 2010; 74 (1): 28-31
22. Garcia-Garcia G, Renoirte-Lopez K, Marquez-Magaña I: Disparities
in renal care in Jalisco, Mexico. Semin Nephrol 2010; 30 (1): 3-7
23. Gordon EJ, Ladner DP, Caicedo JC, Franklin J: Disparities in kidney
transplant outcomes: A review. Semin Nephrol 2010; 30 (1): 81-89
24. 3rd Global WHO Consultation March 2010: Organ Donation
and Transplantation: Strivingto Achieve Self-Sufficiency.
Transplantation 2011; 91 (11): 27-114
25. Bernat JL, D’Alessandro AM, Port FK, Bleck TP, Heard SO, Medina
J, Rosenbaum SH, Devita MA, Gaston RS, Merion RM, Barr ML,
Marks WH, Nathan H, O’connor K, Rudow DL, Leichtman AB,
Schwab P, Ascher NL, Metzger RA, Mc Bride V, Graham W, Wagner
D, Warren J, Delmonico FL: Report of a National conference on
donation after cardiac death. Am J Transplant 2006; 6 (2): 281-291
26. Abraham G, John GT, Sunil S, Fernando EM, Reddy YNV:
Evolution of renal transplantation in India over the last four decades.
NDT Plus 2010; 3 (2): 203-207
27. Shimazono Y: The state of the international organ trade: A
provisional picture based on integration of available information.
Bull World Health Organ 2007; 85 (12): 955-962
28. WorldHealthAssembly 44/1991/REC/1. Annex 6
29. WorldHealthAssembly63.22/2010http://www.who.int/
transplantation/Guiding_PrinciplesTransplantation_WHA63.22en.
pdf Accessed 29/11/2011
30. Participants in the International Summit on Transplant Tourism and
Organ Trafficking Convened by the Transplantation Society and
International Society of Nephrology in Istanbul, Turkey, April 30-
May 2, 2008: The Declaration of Istanbul on organ trafficking and
transplant tourism. Transplantation. 2008; 86 (8): 1013-1018
31. Delmonico FL, Domínguez-Gil B, Matesanz R, Noel L: A call
for government accountability to achieve national self-sufficiency
in organ donation and transplantation. Lancet 2011; 378 (9800):
1414-1418
32. United Nations General Assembly: Political declaration of the
High-level Meeting of the General Assembly on the Prevention and
Control of Non-communicable Diseases A/66/L.1, September 16,
2011

Thank you for copying data from http://www.arastirmax.com